Reinartz, Gabriele http://orcid.org/0000-0002-4869-5986
Pyra, Regina P.
Lenz, Georg
Liersch, Rüdiger
Stüben, Georg
Micke, Oliver
Willborn, Kay
Hess, Clemens F.
Probst, Andreas
Fietkau, Rainer
Jany, Ralf
Schultze, Jürgen
Rübe, Christian
Hirt, Carsten
Fischbach, Wolfgang
Bentz, Martin
Daum, Severin
Pott, Christiane
Tiemann, Markus
Möller, Peter
Neubauer, Andreas
Wilhelm, Martin
Willich, Normann
Berdel, Wolfgang E.
Eich, Hans T.
Article History
Received: 22 October 2018
Accepted: 15 February 2019
First Online: 11 March 2019
Compliance with ethical guidelines
:
: G. Reinartz, R.P. Pyra, G. Lenz, R. Liersch, G. Stüben, O. Micke, K. Willborn, C.F. Hess, A. Probst, R. Jany, J. Schultze, C. Rübe, C. Hirt, W. Fischbach, M. Bentz, S. Daum, C. Pott, M. Tiemann, P. Möller, A. Neubauer, M. Wilhelm, N. Willich, W.E. Berdel and H.T. Eich declare that they have no competing interests. R. Fietkau reports grants, personal fees and non-financial support from Merck Serono, personal fees and non-financial support from Fresenius Kabi, personal fees and non-financial support from Novocure, grants, personal fees and non-financial support from MSD, grants, personal fees and non-financial support from AstraZeneca, personal fees and non-financial support from Brainlab, personal fees and non-financial support from Sennewald GmbH, personal fees and non-financial support from Bristol-Myers Squibb, outside the submitted work.
: The trials were conducted in accordance with the Declaration of Helsinki on Ethical Principles for Medical Research after approval of the Ethical Board of the physicians’ chamber of Westfalia-Lippe and the Westfalian Wilhelms-University of Münster. The studies were reviewed by the local Ethical Committees (institutional review boards) of the involved trials sites.